Plain-English translation of NCT01306084 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand how viruses like herpes and COVID-19 behave in different people's bodies — especially how they evolve, mutate, and sometimes become resistant to antiviral treatments. By collecting samples and information from people with viral infections or who have been exposed to them, scientists can study these viruses more closely and learn how to better prevent and treat future viral outbreaks.
Viruses behave differently depending on whether a person's immune system is strong or weakened. In immunocompromised people, viruses can change more rapidly and develop resistance to medications. This study exists to fill gaps in our knowledge about how viruses naturally evolve and develop resistance, so doctors and scientists can better predict and prevent future epidemics and develop better treatments.
You likely qualify if…
You likely don't qualify if…
Depending on which group you join, you may donate blood samples, nasal or throat swabs, or other samples over several visits. You will answer questions about your health history and symptoms, and the study team may review your medical records or past lab work. Some participants may have their immune responses tested through blood work, and samples may be stored for future research to help scientists understand viral evolution better.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
United States